Farxiga, Jardiance, & Invokana Lawyer
The diabetes medications Farxiga, Jardiance, and Invokana have become the subject of recent public scrutiny with the release of a recent FDA safety communication stating that SLGT2 inhibitors “may result in a serious condition of too much acid in the blood.” Those who are treating with the type 2 diabetes drugs and those who have received such a diagnosis may be concerned about their next course of action. Attorneys are currently evaluating potential legal claims against the makers of these drugs.
Those who claim to have been harmed by medications intended to maintain healthy glycemic levels may consider retaining a lawyer. Filing a lawsuit against a global pharmaceutical company is never an easy task, considering the vast financial resources available to drug makers. A knowledgeable Farxiga or Invokana attorney may be able to help.
What an Invokana lawyer can do for you
Any future SGLT2 inhibitor lawsuit will likely be based on common allegations of failure to warn, defective manufacture / design, and breach of warranties. Potential plaintiffs need an attorney who is familiar with drug injury cases and has the trial experience to successfully argue the claim before a jury and win.
A legal advocate will be able to:
- Fight deep-pocketed drug companies: Johnson & Johnson (maker of Invokana), AstraZeneca (Farxiga) and Boehringer Ingelheim (Jardiance) are multi-billion dollar entities that are no strangers to protracted litigation. Your lawyer should have prior experience bringing drug injury lawsuits against Big Pharma.
- Marshal crucial evidence: A good attorney will quickly obtain all medical records and documentation that details use of the SGLT2 inhibitor and your subsequent injuries, hospitalization and economic losses.
- Handle pre-trial procedures: Your lawyer will depose key witnesses, manage pre-trial discovery, and thoroughly prepare for a trial.
- Negotiate a favorable settlement: When a large volume of lawsuits are filed against a single defendant, companies may opt to settle cases out of court. An expert on SGLT2 inhibitor litigation,a legal advocate can effectively secure the strongest settlement on your behalf.
- Argue your case before a jury: If mediation efforts fail, your attorney is fully prepared to go to trial and present convincing evidence and testimony from authoritative experts that ensure the best outcome possible.
- Join consolidated litigation: Farxiga and Invokana lawsuits are only just emerging, but if litigation continues to intensify, the courts may establish a mass tort or multidistrict litigation. Your lawyer will be able to collaborate with other plaintiff attorneys on a federal or state level.
SGLT2 inhibitor lawsuit criteria
Potential legal claims against the manufacturers of these medications are in the earliest stages of development. In May 2015, the FDA issued a safety communication that SGLT2 inhibitors may cause high acid levels in the bloodstream (ketones), a serious condition called ketoacidosis, that may require hospitalization. Though there have been no fatalities reported in connection with Invokana, Farxiga, and similar medications, untreated diabetic ketoacidosis (DKA) can lead to serious complication including kidney failure, coma or even death.
This class of type 2 diabetes medication is relatively new to the market, receiving FDA approval in 2013 and 2014. As more post-market data is gathered from patients, the federal agency will continue to investigate to determine whether further action is required.
Patients may have a viable SGLT2 inhibitor lawsuit if they:
- Took one of the following diabetes drugs under the care of their doctor: Invokana, Invokamet, Jardiance, Farxiga, Glyxambi, or Xigduo XR
- Suffered ketoacidosis and resulting complications such as kidney failure or heart attack
- Sought medical attention to treat their resulting health condition and injuries.
Why Invokana & Farxiga patients may need an attorney
It’s virtually impossible to pursue compensation against Big Pharma without the legal savvy of an experienced attorney–someone who has the resources, connections and work ethic to aggressively fight for every dime owed to the victim or their surviving family members. For this reason, it’s imperative that you choose a respected lawyer who understands the nuances of pharmaceutical litigation, thus improving your chances of a favorable settlement or verdict.
Whether tried before a jury or settled during mediation, a successful lawsuit can recoup money for all medical bills, related therapies, lost wages, pain and suffering, funeral expenses and other, non-economic losses. Don’t trust your family’s financial future with the unknown – choose a dangerous drug lawyer with major settlements and court awards under his or her belt.
Tips for choosing your legal advocate
Every state has its own statute of limitations for filing an Invokana lawsuit, which is why it’s important to start the legal process as soon as possible.
For your best shot at a successful recovery, select a lawyer based on these tips:
- Go with experience: SGLT2 inhibitor lawsuits are still relatively new; be sure your attorney has ample experience litigating other pharmaceutical claims.
- Track record: A demonstrable track record of past court awards and settlements recovered against drug makers
- Good communication skills: First and foremost, you must feel comfortable discussing private medical details of your injuries with your lawyer. Choose an attorney with whom you communicate well. He or she must respond promptly to phone calls and emails, and be available to answer your questions.
- Operates on a contingency basis: Law firms that work on contingency have the financial means to take on your case without upfront payments. In essence, your legal fees come directly from any jury award or settlement, thus removing any risk. This scenario often proves beneficial to both plaintiff and attorney, who will work hard for the maximum compensation available.
- EndocrineWeb.com, SGLT2 Inhibitors and Diabetic Ketoacidosis: What's Behind the FDA Warning http://www.endocrineweb.com/news/diabetes/15021-whats-behind-fdas-warning-about-diabetic-ketoacidosis-sglt2-inhibitors
- Reuters, FDA warns on newer class of type 2 diabetes drugs http://www.reuters.com/article/2015/05/15/us-fda-diabetes-idUSKBN0O01P520150515